These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 2836336)

  • 21. Hearing loss in experimental cytomegalovirus infection of the guinea pig inner ear: prevention by systemic immunity.
    Woolf NK; Harris JP; Ryan AF; Butler DM; Richman DD
    Ann Otol Rhinol Laryngol; 1985; 94(4 Pt 1):350-6. PubMed ID: 2992353
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Peripheral blood mononuclear cell-mediated cytolytic activity during cytomegalovirus (CMV) infection of guinea pigs.
    Harrison CJ; Myers MG
    J Med Virol; 1988 Aug; 25(4):441-53. PubMed ID: 2844985
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cytomegalovirus infection elicits a conserved chemokine response from human and guinea pig amnion cells.
    Putri DS; Berkebile ZW; Mustafa HJ; Fernández-Alarcón C; Abrahante JE; Schleiss MR; Bierle CJ
    Virology; 2020 Sep; 548():93-100. PubMed ID: 32838950
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cytomegaloviral infections in the guinea pig: experimental models for human disease.
    Bia FJ; Griffith BP; Fong CK; Hsiung GD
    Rev Infect Dis; 1983; 5(2):177-95. PubMed ID: 6302812
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Demonstration of cytomegalovirus and retrovirus pseudotypes in cultured guinea pig cells.
    Lerner-Tung MB; Crouch JY; Hsiung GD
    Virology; 1991 Feb; 180(2):826-30. PubMed ID: 1703374
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Identification of GPCMV infected cells in vitro and in vivo with a monoclonal antibody.
    Jones CT; Keay SK; Swoveland PT
    J Virol Methods; 1994 Jul; 48(2-3):133-44. PubMed ID: 7989431
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Protection against congenital cytomegalovirus (CMV) disease, conferred by a replication-disabled, bacterial artificial chromosome (BAC)-based DNA vaccine.
    Schleiss MR; Stroup G; Pogorzelski K; McGregor A
    Vaccine; 2006 Sep; 24(37-39):6175-86. PubMed ID: 16879902
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Studies on cytomegalovirus endophthalmitis. Virus isolation and immunohistological studies after intraperitoneal and intraocular inoculation].
    Karino K; Sasaki K
    Nippon Ganka Gakkai Zasshi; 1985 Nov; 89(11):1282-8. PubMed ID: 3004163
    [No Abstract]   [Full Text] [Related]  

  • 29. Cytomegalovirus infection in guinea pigs. III. Persistent viruria, blood transmission, and viral interference.
    Bia FJ; Hastings K; Hsiung GD
    J Infect Dis; 1979 Dec; 140(6):914-20. PubMed ID: 232118
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Inbred guinea pig model of intrauterine infection with cytomegalovirus.
    Griffith BP; McCormick SR; Booss J; Hsiung GD
    Am J Pathol; 1986 Jan; 122(1):112-9. PubMed ID: 3002178
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Preconception vaccination with a glycoprotein B (gB) DNA vaccine protects against cytomegalovirus (CMV) transmission in the guinea pig model of congenital CMV infection.
    Schleiss MR; Bourne N; Bernstein DI
    J Infect Dis; 2003 Dec; 188(12):1868-74. PubMed ID: 14673766
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cytomegalovirus infection in weanling guinea pigs.
    Connor WS; Johnson KP
    J Infect Dis; 1976 Nov; 134(5):442-9. PubMed ID: 186540
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Murine cytomegalovirus infection in the spleen and its relationship to immunosuppression.
    Loh L; Hudson JB
    Infect Immun; 1981 Jun; 32(3):1067-72. PubMed ID: 6265371
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Protection against congenital cytomegalovirus infection and disease in guinea pigs, conferred by a purified recombinant glycoprotein B vaccine.
    Schleiss MR; Bourne N; Stroup G; Bravo FJ; Jensen NJ; Bernstein DI
    J Infect Dis; 2004 Apr; 189(8):1374-81. PubMed ID: 15073673
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Immunogenicity evaluation of DNA vaccines that target guinea pig cytomegalovirus proteins glycoprotein B and UL83.
    Schleiss MR; Bourne N; Jensen NJ; Bravo F; Bernstein DI
    Viral Immunol; 2000; 13(2):155-67. PubMed ID: 10892996
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cytomegalovirus infection in guinea pigs. I. Viremia during acute primary and chronic persistent infection.
    Hsiung GD; Choi YC; Bia F
    J Infect Dis; 1978 Aug; 138(2):191-6. PubMed ID: 210238
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Enhancement of cytomegalovirus infection during pregnancy in guinea pig.
    Griffith BP; Lucia HL; Tillbrook JL; Hsiung GD
    J Infect Dis; 1983 Jun; 147(6):990-8. PubMed ID: 6304208
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Impairment in neurocognitive function following experimental neonatal guinea pig cytomegalovirus infection.
    Fernández-Alarcón C; Meyer LE; McVoy MA; Lokensgard JR; Hu S; Benneyworth MA; Anderholm KM; Janus BC; Schleiss MR
    Pediatr Res; 2021 Mar; 89(4):838-845. PubMed ID: 32555536
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Lymphadenopathy during cytomegalovirus-induced mononucleosis in guinea pigs.
    Lucia HL; Griffith BP; Hsiung GD
    Arch Pathol Lab Med; 1985 Nov; 109(11):1019-23. PubMed ID: 2996461
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Susceptibility of fetal guinea pig brain cell cultures to replicating guinea pig cytomegalovirus infection is increased with increasing fetal age: infection of astrocytes.
    Kari B; Gehrz R
    J Virol; 1986 Jun; 58(3):960-2. PubMed ID: 3009898
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.